EP1799685
POLYMORPHIC FORMS OF THE PHOSPHATE SALT OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE
:
EP einkaleyfi: Þýðing ekki lögð inn:
12.9.2005:
28.3.2012:
05799991.4
:
POLYMORPHIC FORMS OF THE PHOSPHATE SALT OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE
12.9.2005
28.3.2012
:
Pfizer Inc.:
235 East 42nd Street, 10017, New York, NY, US
:
Cancer Research Technology Limited:
Sardinia House, Sardinia Street, London WC2A 3NL, GB
:
LIU, Jia,Agouron Pharmaceuticals, Inc.:
San Diego, CA, US
:
NAYYAR, Naresh,Agouron Pharmaceuticals, Inc.:
San Diego, CA, US
:
GUO, MingAgouron Pharmaceuticals, Inc.A Pfizer Company:
San Diego, CA, US
:
WU, Zhen-Ping,Agouron Pharmaceuticals, Inc.:
San Diego, CA, US
:
BORER Bennett C.,Agouron Pharmaceuticals, Inc.:
San Diego, CA, US
:
SRIRANGAM, A.N.,Agouron Pharmaceuticals, Inc.:
San Diego, CA, US
:
MITCHELL, Mark B.,Agouron Pharmaceuticals, Inc.:
San Diego, CA, US
:
LI, Yi,Agouron Pharmaceuticals, Inc.:
San Diego, CA, US
:
CHU, Jan-Jon,Agouron Pharmaceuticals, Inc.:
San Diego,, US
:
612459 P:
22.9.2004:
US
:
679296 P:
9.5.2005:
US
:
WO2006033007:
12.9.2005
:
C07D 487/06, A61K 31/55, A61P 35/00, A61P 25/00